Xeris Pharmaceuticals Announces Proposed Public Offerings of $20 Million of Common Stock and $60 Million of Convertible Senior Notes
Stock Information for Xeris Biopharma Holdings Inc.
Loading
Please wait while we load your information from QuoteMedia.